Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Human papillomavirus (HPV) infection is responsible for many cancers in both women and
men. Cervical cancer, caused by HPV, is the fourth most common cancer among women …

Every year in the United States more than 12,000 women are diagnosed with cervical
cancer, a disease principally caused by human papillomavirus (HPV). Bivalent and …

Human papillomavirus (HPV) affects approximately 80% of individuals, irrespective of
gender, and is implicated in various cancers. Existing HPV vaccines, while safe and …

• A number of obstacles to uptake of the HPV vaccine in boys include not receiving a
recommendation from a doctor or health care provider, lack of information about the HPV …

Backgrounds As HPV is a sexually transmitted virus, men are crucial in the prevention of
cervical cancer, but research about men's awareness on cervical cancer is limited …

Background Uptake of human papillomavirus (HPV) vaccine among girls in the Dutch
immunization program has plateaued at around 60%. Vaccinating boys may be an …

In Canada, the human papillomavirus (HPV) vaccine is licensed and recommended for
females and males. Although all Canadian jurisdictions fund school-based HPV vaccine …

Background Completed human papillomavirus (HPV) vaccination by age 16 years among
women in Switzerland ranges from 17 to 75% across 26 cantons. The consequences of …

Introduction: Girls-only vaccination against human papillomavirus (HPV) type 16 and 18 was
implemented in the Netherlands in 2009. Despite the evidence of the efficacy against …